Onconetix, Inc. (ONCO): Nasdaq/NYSE listing notice — Blue Water Biotech (BWV) receives Nasdaq bid price deficiency notice

Onconetix, Inc.

Notice from Nasdaq on Sept 18, 2023 for closing bid below $1.00 for 30 consecutive days.
Company has 180 days, until March 16, 2024, to regain compliance by closing at $1.00+ for 10 days.
May qualify for second 180-day compliance period; considering reverse stock split if needed.
No immediate effect on listing; company monitoring options.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Onconetix, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

September 18, 2023, Blue Water Biotech, Inc., a Delaware corporation (the “ Company ”), received a written notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) which sets forth the minimum bid price requirement for continued listing on the Nasdaq Capital Market (the “ Minimum Bid Requirement ”) as the bid price of the Company’s common stock, par value $0.00001 per share (the “ Common Stock ”), had closed below $1.00 per share for 30 cons

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-078811

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.